120 related articles for article (PubMed ID: 20631076)
1. FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinoma.
Mikse OR; Blake DC; Jones NR; Sun YW; Amin S; Gallagher CJ; Lazarus P; Weisz J; Herzog CR
Cancer Res; 2010 Aug; 70(15):6205-15. PubMed ID: 20631076
[TBL] [Abstract][Full Text] [Related]
2. FOXO3a elicits a pro-apoptotic transcription program and cellular response to human lung carcinogen nicotine-derived nitrosaminoketone (NNK).
Blake DC; Mikse OR; Freeman WM; Herzog CR
Lung Cancer; 2010 Jan; 67(1):37-47. PubMed ID: 19380174
[TBL] [Abstract][Full Text] [Related]
3. FoxO3a gene is a target of deletion in mouse lung adenocarcinoma.
Herzog CR; Blake DC; Mikse OR; Grigoryeva LS; Gundermann EL
Oncol Rep; 2009 Oct; 22(4):837-43. PubMed ID: 19724863
[TBL] [Abstract][Full Text] [Related]
4. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
Renault VM; Thekkat PU; Hoang KL; White JL; Brady CA; Kenzelmann Broz D; Venturelli OS; Johnson TM; Oskoui PR; Xuan Z; Santo EE; Zhang MQ; Vogel H; Attardi LD; Brunet A
Oncogene; 2011 Jul; 30(29):3207-21. PubMed ID: 21423206
[TBL] [Abstract][Full Text] [Related]
5. Adenylosuccinate synthetase 1 gene is a novel target of deletion in lung adenocarcinoma.
Miller JC; Blake DC; Herzog CR
Mol Carcinog; 2009 Dec; 48(12):1116-22. PubMed ID: 19603421
[TBL] [Abstract][Full Text] [Related]
6. The carcinogen (7R,8S)-dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene induces Cdc25B expression in human bronchial and lung cancer cells.
Oguri T; Singh SV; Nemoto K; Lazo JS
Cancer Res; 2003 Feb; 63(4):771-5. PubMed ID: 12591724
[TBL] [Abstract][Full Text] [Related]
7. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
9. FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms.
Czymai T; Viemann D; Sticht C; Molema G; Goebeler M; Schmidt M
J Biol Chem; 2010 Apr; 285(14):10163-78. PubMed ID: 20123982
[TBL] [Abstract][Full Text] [Related]
10. The role of FOXO3 in DNA damage response in thyrocytes.
Klagge A; Weidinger C; Krause K; Jessnitzer B; Gutknecht M; Fuhrer D
Endocr Relat Cancer; 2011 Oct; 18(5):555-64. PubMed ID: 21712344
[TBL] [Abstract][Full Text] [Related]
11. Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines.
Khan QA; Anderson LM
Toxicol Appl Pharmacol; 2001 Jun; 173(2):105-13. PubMed ID: 11384212
[TBL] [Abstract][Full Text] [Related]
12. Sp1-mediated microRNA-182 expression regulates lung cancer progression.
Yang WB; Chen PH; Hsu T; Fu TF; Su WC; Liaw H; Chang WC; Hung JJ
Oncotarget; 2014 Feb; 5(3):740-53. PubMed ID: 24519909
[TBL] [Abstract][Full Text] [Related]
13. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
[TBL] [Abstract][Full Text] [Related]
14. Activation of the aromatic hydrocarbon receptor pathway is not sufficient for transcriptional repression of BRCA-1: requirements for metabolism of benzo[a]pyrene to 7r,8t-dihydroxy-9t,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
Jeffy BD; Chirnomas RB; Chen EJ; Gudas JM; Romagnolo DF
Cancer Res; 2002 Jan; 62(1):113-21. PubMed ID: 11782367
[TBL] [Abstract][Full Text] [Related]
15. [Study on lung carcinogenesis associated genes in human lung squamous cell carcinoma and malignant transformation of human bronchial epithelial cells induced by carcinogen].
Lü JC; Chen JK; Ji WD; Jiang YG; Shi LY; Wu ZL; He M; Zeng BH
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2146-51. PubMed ID: 14720424
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients.
Cho EC; Kuo ML; Liu X; Yang L; Hsieh YC; Wang J; Cheng Y; Yen Y
Oncotarget; 2014 Jul; 5(13):4834-44. PubMed ID: 24947616
[TBL] [Abstract][Full Text] [Related]
17. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
[TBL] [Abstract][Full Text] [Related]
18. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of the transcriptional regulator p8 results in increased autophagy and apoptosis, and causes impaired heart function.
Kong DK; Georgescu SP; Cano C; Aronovitz MJ; Iovanna JL; Patten RD; Kyriakis JM; Goruppi S
Mol Biol Cell; 2010 Apr; 21(8):1335-49. PubMed ID: 20181828
[TBL] [Abstract][Full Text] [Related]
20. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.
Weidinger C; Krause K; Mueller K; Klagge A; Fuhrer D
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1361-71. PubMed ID: 21752881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
